Cover
Cover - shares | 3 Months Ended | |
Dec. 31, 2023 | Jul. 29, 2024 | |
Document Information [Line Items] | ||
Document Type | 10-Q | |
Document Quarterly Report | true | |
Document Transition Report | false | |
Entity Interactive Data Current | Yes | |
Amendment Flag | false | |
Document Period End Date | Dec. 31, 2023 | |
Document Fiscal Year Focus | 2024 | |
Document Fiscal Period Focus | Q1 | |
Entity Information [Line Items] | ||
Entity Registrant Name | YUMMIES, INC. | |
Entity Central Index Key | 0001073748 | |
Entity File Number | 000-32361 | |
Entity Tax Identification Number | 87-0615629 | |
Entity Incorporation, State or Country Code | NV | |
Current Fiscal Year End Date | --09-30 | |
Entity Current Reporting Status | Yes | |
Entity Shell Company | false | |
Entity Filer Category | Non-accelerated Filer | |
Entity Small Business | true | |
Entity Emerging Growth Company | true | |
Entity Ex Transition Period | false | |
Entity Contact Personnel [Line Items] | ||
Entity Address, Address Line One | 6F., No.516, Sec. 1, Neihu Road, Neihu District. | |
Entity Address, Address Line Two | Neihu District | |
Entity Address, City or Town | Taipei City | |
Entity Address, Country | TW | |
Entity Address, Postal Zip Code | 114 | |
Entity Phone Fax Numbers [Line Items] | ||
City Area Code | +88 | |
Local Phone Number | 6287511886 | |
Entity Listings [Line Items] | ||
No Trading Symbol Flag | true | |
Entity Common Stock, Shares Outstanding | 449,626,500 |
Condensed Consolidated Interim
Condensed Consolidated Interim Balance Sheets - USD ($) | Dec. 31, 2023 | Sep. 30, 2023 |
Current Assets: | ||
Bank | $ 215 | $ 176 |
Total current assets | 215 | 176 |
Total Assets | 215 | 176 |
Current Liabilities: | ||
Accounts payable | 10,826 | 13,948 |
Notes payable, stockholders | ||
Total net current liabilities | 10,826 | 13,948 |
Stockholders’ Deficit: | ||
Common stock, $0.0001 par value, 450,000,000 shares authorized, 449,627,500 issued and outstanding as of December 31, 2023 and September 30, 2023 | ||
Preferred stock $0.0001 par value, 50,000,000 shares authorized, -0- and -0- issued and outstanding | 47,217 | 47,217 |
Additional paid-in capital | 291,889 | 288,404 |
Accumulated deficit | (349,717) | (349,393) |
Total Stockholders’ Deficit | (10,611) | (13,772) |
Total Liabilities and Stockholders’ Deficit | $ 215 | $ 176 |
Condensed Consolidated Interi_2
Condensed Consolidated Interim Balance Sheets (Parentheticals) - $ / shares | Dec. 31, 2023 | Sep. 30, 2023 |
Statement of Financial Position [Abstract] | ||
Common stock, par value (in Dollars per share) | $ 0.0001 | $ 0.0001 |
Common stock, shares authorized | 450,000,000 | 450,000,000 |
Common stock, shares issued | 449,627,500 | 449,627,500 |
Common stock, shares outstanding | 449,627,500 | 449,627,500 |
Preferred stock, par value (in Dollars per share) | $ 0.0001 | $ 0.0001 |
Preferred stock, shares authorized | 50,000,000 | 50,000,000 |
Preferred stock, shares issued | 0 | 0 |
Preferred stock, shares outstanding | 0 | 0 |
Condensed Consolidated Interi_3
Condensed Consolidated Interim Statements of Operations (Unaudited) - USD ($) | 3 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Income Statement [Abstract] | ||
Revenues – related party | ||
Expenses, general and administrative | (324) | (10,687) |
Operating loss | (324) | (10,687) |
Loss before provision for income taxes | (324) | (10,687) |
Provision for income taxes | ||
Net loss | $ (324) | $ (10,687) |
Weighted average shares outstanding (in Shares) | 449,626,500 | 449,626,500 |
Net loss per share (in Dollars per share) |
Condensed Consolidated Statemen
Condensed Consolidated Statements of Stockholders’ Deficit (Unaudited) - USD ($) | Common Stock | Additional Paid-in Capital | Accumulated Deficit | Total |
Balance at Sep. 30, 2022 | $ 47,217 | $ 257,836 | $ (286,318) | $ 18,735 |
Balance (in Shares) at Sep. 30, 2022 | 449,626,500 | |||
Net loss | (10,687) | (10,687) | ||
Balance at Dec. 31, 2022 | $ 47,217 | 259,136 | (297,005) | 9,348 |
Balance (in Shares) at Dec. 31, 2022 | 449,626,500 | |||
Balance at Sep. 30, 2022 | $ 47,217 | 257,836 | (286,318) | 18,735 |
Balance (in Shares) at Sep. 30, 2022 | 449,626,500 | |||
Contribution by shareholder for company expenses paid directly by shareholder | 1,300 | 1,300 | ||
Balance at Dec. 31, 2023 | $ 47,217 | 291,889 | (349,717) | (10,611) |
Balance (in Shares) at Dec. 31, 2023 | 449,626,500 | |||
Balance at Sep. 30, 2023 | $ 47,217 | 288,404 | (349,393) | (13,772) |
Balance (in Shares) at Sep. 30, 2023 | 449,626,500 | |||
Contribution by shareholder for company expenses paid directly by shareholder | 3,485 | 3,485 | ||
Net loss | (324) | (324) | ||
Balance at Dec. 31, 2023 | $ 47,217 | $ 291,889 | $ (349,717) | $ (10,611) |
Balance (in Shares) at Dec. 31, 2023 | 449,626,500 |
Condensed Consolidated Interom
Condensed Consolidated Interom Statements of Cash Flows (Unaudited) - USD ($) | 3 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Cash flows from operating activities: | ||
Net loss | $ (324) | $ (10,687) |
Adjustments to reconcile net loss to cash provided by operating activities: | ||
(Decrease) / Increase in accounts payable | (3,122) | 9,000 |
Net cash used in operating activities | (3,466) | (1,687) |
Cash flows from financing activities: | ||
Contribution from a shareholder | 3,485 | 1,300 |
Net cash generated from financing activities | 3,485 | 1,300 |
Net increase (decrease) in cash | 39 | (387) |
Cash, beginning of period | 176 | 420 |
Cash, end of period | 215 | 33 |
Supplemental disclosure of cash flow information: | ||
Interest paid |
Summary of Business and Signifi
Summary of Business and Significant Accounting Policies | 3 Months Ended |
Dec. 31, 2023 | |
Summary of Business and Significant Accounting Policies [Abstract] | |
Summary of Business and Significant Accounting Policies | 1. Summary of Business and Significant Accounting Policies a. Summary of Business The Company was incorporated under the laws of the State of Nevada on June 10, 1998 and commenced it business as consulting, training and event Management Company through its subsidiary. b. Basis of Presentation The accompanying financial statements have been prepared in accordance with generally accepted accounting principles (“GAAP”) as promulgated in the United States of America. c. Cash Flows For purposes of the statement of cash flows, the Company considers all highly liquid investments purchased with a maturity of three months or less to be cash or cash equivalents. d. Net Loss Per Share The net loss per share calculation is based on the weighted average number of shares outstanding during the period. Net loss per common share is computed pursuant to section 260-10-45 of the FASB Accounting Standards Codification. Basic net loss per common share is computed by dividing net loss by the weighted average number of shares of common stock outstanding during the period. Diluted net loss per common share is computed by dividing net loss by the weighted average number of shares of common stock and potentially dilutive outstanding shares of common stock during the period to reflect the potential dilution that could occur from common shares issuable through contingent share arrangements, stock options and warrants. There were no potentially dilutive common shares outstanding for the years ended December 31, 2023 and 2022. e. Use of Estimates The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect certain reported amounts and disclosures. Accordingly, actual results could differ from those estimates. f. Fair Value of Financial Instruments ASC 820-10 requires entities to disclose the fair value of financial instruments, both assets and liabilities recognized and not recognized on the balance sheet, for which it is practicable to estimate fair value. ASC 820-10 defines the fair value of a financial instrument as the amount at which the instrument could be exchanged in a current transaction between willing parties. As of December 31, 2023 and 2022, the carrying value of certain financial instruments approximates fair value due to the short-term nature of such instruments.The Company follows paragraph 825-10-50-10 of the FASB Accounting Standards Codification for disclosures about fair value of its financial instruments and paragraph 820-10-35-37 of the FASB Accounting Standards Codification (“Paragraph 820-10-35-37”) to measure the fair value of its financial instruments. Paragraph 820-10-35-37 establishes a framework for measuring fair value in accounting principles generally accepted in the United States of America (U.S. GAAP), and expands disclosures about fair value measurements. To increase consistency and comparability in fair value measurements and related disclosures, Paragraph 820-10-35-37 establishes a fair value hierarchy which prioritizes the inputs to valuation techniques used to measure fair value into three (3) broad levels. The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. The three (3) levels of fair value hierarchy defined by Paragraph 820-10-35-37 are described below: Level 1 - Quoted market prices available in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date. Level 2 - Inputs include quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the asset or liability (e.g., interest rates, yield curves, etc.), and inputs that are derived principally from or corroborated by observable market data by correlation or other means (market corroborated inputs). Level 3 - Unobservable inputs that reflect our assumptions about the assumptions that market participants would use in pricing the asset or liability. The Company’s financial instruments are consisted principally of accrued expenses and short term debt. The carrying amounts of such financial instruments in the accompanying balance sheets approximate their fair values due to their relatively short-term nature. g. Recently Issued Accounting Pronouncements There are no recently Issued Accounting Pronouncements that may have a material impact on financial position and results. h. Principles of Consolidation The accompanying consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary, Yummies, SG. All significant intercompany transactions and balances have been eliminated. i. Foreign Currency Translation The Company follows Section 830-10-45 of the FASB Accounting Standards Codification (“Section 830-10-45”) for foreign currency translation to translate the financial statements of the foreign subsidiary from the functional currency, generally the local currency, into U.S. Dollars. Section 830-10-45 sets out the guidance relating to how a reporting entity determines the functional currency of a foreign entity (including of a foreign entity in a highly inflationary economy), re-measures the books of record (if necessary), and characterizes transaction gains and losses. the assets, liabilities, and operations of a foreign entity shall be measured using the functional currency of that entity. An entity’s functional currency is the currency of the primary economic environment in which the entity operates; normally, that is the currency of the environment, or local currency, in which an entity primarily generates and expends cash. The functional currency of each foreign subsidiary is determined based on management’s judgment and involves consideration of all relevant economic facts and circumstances affecting the subsidiary. Generally, the currency in which the subsidiary transacts a majority of its transactions, including billings, financing, payroll and other expenditures, would be considered the functional currency, but any dependency upon the parent and the nature of the subsidiary’s operations must also be considered. If a subsidiary’s functional currency is deemed to be the local currency, then any gain or loss associated with the translation of that subsidiary’s financial statements is included in accumulated other comprehensive income. However, if the functional currency is deemed to be the U.S. Dollar, then any gain or loss associated with the re-measurement of these financial statements from the local currency to the functional currency would be included in the consolidated statements of comprehensive income (loss). If the Company disposes of foreign subsidiaries, then any cumulative translation gains or losses would be recorded into the consolidated statements of comprehensive income (loss). If the Company determines that there has been a change in the functional currency of a subsidiary to the U.S. Dollar, any translation gains or losses arising after the date of change would be included within the statement of comprehensive income (loss). Based on an assessment of the factors discussed above, the management of the Company determined the relevant subsidiaries’ local currencies to be their respective functional currencies. j. Going Concern As shown in the accompanying financial statements, the Company incurred a net loss of $324 during the three months ended December 31, 2022 and accumulated losses of $349,717 since inception at June 10, 1998 |
Issuance of Common Stock
Issuance of Common Stock | 3 Months Ended |
Dec. 31, 2023 | |
Issuance of Common Stock [Abstract] | |
Issuance of Common Stock | 2. Issuance of Common Stock On December 17, 2018, the Company amended and restated its articles of incorporation. The authorized shares of common stock were increased from 50,000,000 shares to 450,000,000 shares and the par value was changed from $0.001 to $0.0001 per share. The change has been reflected retroactively in the accompanying financial statements. In addition, the Company authorized the issuance of 50,000,000 shares of preferred stock having a par value of $0.0001 per share. As of December 31, 2020, no preferred shares have been issued. In February 2019, pursuant to an exemption from the registration requirements of the Securities Act of 1933, as amended, (the “Securities Act”) provided by Section 4(a)(2) and Regulation S thereunder, the Company sold 446,472,607 shares of its common stock at a price of $0.0001 per share for an aggregate price of $44,647. Issuance costs of $45,725 were offset against additional paid in capital in the accompanying financial statements. In October, 2019, the Company issued 3,527,393 shares of its $.0001 par value common stock for an aggregate price of $352.74. In August 2020, the Company issued 121,500 shares of its $.0001 par value common stock for an aggregate price of $12.15. |
Warrants and Stock Options
Warrants and Stock Options | 3 Months Ended |
Dec. 31, 2023 | |
Warrants and Stock Options [Abstract] | |
Warrants and Stock Options | 3. Warrants and Stock Options No options or warrants are outstanding to acquire the Company’s common stock. |
Income Taxes
Income Taxes | 3 Months Ended |
Dec. 31, 2023 | |
Income Taxes [Abstract] | |
Income Taxes | 4. Income Taxes The Company has no taxable income under Federal or State tax laws. The Company has loss carry forwards totaling $349,717 and $297,005 and during the three-month period ended December 31, 2023 and 31 December 2022 that may be offset against future federal income taxes. If not used, the carry forwards will expire between 2024 and 2038. Due to the Company being in the development stage and incurring net operating losses, a valuation allowance has been provided to reduce the deferred tax assets from the net operating losses to zero. Therefore, there are no tax benefits recognized in the accompanying statement of operations. The income tax effect of the Tax Cuts and Jobs Act have been completed in accordance with FASB ASC740. |
Subsequent Events
Subsequent Events | 3 Months Ended |
Dec. 31, 2023 | |
Subsequent Events [Abstract] | |
Subsequent Events | 5. Subsequent Events Management has evaluated subsequent events through July 29, 2024, the date on which the financial statements were available to be issued. |
Pay vs Performance Disclosure
Pay vs Performance Disclosure - USD ($) | 3 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Pay vs Performance Disclosure | ||
Net Income (Loss) | $ (324) | $ (10,687) |
Insider Trading Arrangements
Insider Trading Arrangements | 3 Months Ended |
Dec. 31, 2023 | |
Trading Arrangements, by Individual | |
Rule 10b5-1 Arrangement Adopted | false |
Non-Rule 10b5-1 Arrangement Adopted | false |
Rule 10b5-1 Arrangement Terminated | false |
Non-Rule 10b5-1 Arrangement Terminated | false |
Accounting Policies, by Policy
Accounting Policies, by Policy (Policies) | 3 Months Ended |
Dec. 31, 2023 | |
Summary of Business and Significant Accounting Policies [Abstract] | |
Summary of Business | a. Summary of Business The Company was incorporated under the laws of the State of Nevada on June 10, 1998 and commenced it business as consulting, training and event Management Company through its subsidiary. |
Basis of Presentation | b. Basis of Presentation The accompanying financial statements have been prepared in accordance with generally accepted accounting principles (“GAAP”) as promulgated in the United States of America. |
Cash Flows | c. Cash Flows For purposes of the statement of cash flows, the Company considers all highly liquid investments purchased with a maturity of three months or less to be cash or cash equivalents. |
Net Loss Per Share | d. Net Loss Per Share The net loss per share calculation is based on the weighted average number of shares outstanding during the period. Net loss per common share is computed pursuant to section 260-10-45 of the FASB Accounting Standards Codification. Basic net loss per common share is computed by dividing net loss by the weighted average number of shares of common stock outstanding during the period. Diluted net loss per common share is computed by dividing net loss by the weighted average number of shares of common stock and potentially dilutive outstanding shares of common stock during the period to reflect the potential dilution that could occur from common shares issuable through contingent share arrangements, stock options and warrants. There were no potentially dilutive common shares outstanding for the years ended December 31, 2023 and 2022. |
Use of Estimates | e. Use of Estimates The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect certain reported amounts and disclosures. Accordingly, actual results could differ from those estimates. |
Fair Value of Financial Instruments | f. Fair Value of Financial Instruments ASC 820-10 requires entities to disclose the fair value of financial instruments, both assets and liabilities recognized and not recognized on the balance sheet, for which it is practicable to estimate fair value. ASC 820-10 defines the fair value of a financial instrument as the amount at which the instrument could be exchanged in a current transaction between willing parties. As of December 31, 2023 and 2022, the carrying value of certain financial instruments approximates fair value due to the short-term nature of such instruments.The Company follows paragraph 825-10-50-10 of the FASB Accounting Standards Codification for disclosures about fair value of its financial instruments and paragraph 820-10-35-37 of the FASB Accounting Standards Codification (“Paragraph 820-10-35-37”) to measure the fair value of its financial instruments. Paragraph 820-10-35-37 establishes a framework for measuring fair value in accounting principles generally accepted in the United States of America (U.S. GAAP), and expands disclosures about fair value measurements. To increase consistency and comparability in fair value measurements and related disclosures, Paragraph 820-10-35-37 establishes a fair value hierarchy which prioritizes the inputs to valuation techniques used to measure fair value into three (3) broad levels. The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. The three (3) levels of fair value hierarchy defined by Paragraph 820-10-35-37 are described below: Level 1 - Quoted market prices available in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date. Level 2 - Inputs include quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the asset or liability (e.g., interest rates, yield curves, etc.), and inputs that are derived principally from or corroborated by observable market data by correlation or other means (market corroborated inputs). Level 3 - Unobservable inputs that reflect our assumptions about the assumptions that market participants would use in pricing the asset or liability. The Company’s financial instruments are consisted principally of accrued expenses and short term debt. The carrying amounts of such financial instruments in the accompanying balance sheets approximate their fair values due to their relatively short-term nature. |
Recently Issued Accounting Pronouncements | g. Recently Issued Accounting Pronouncements There are no recently Issued Accounting Pronouncements that may have a material impact on financial position and results. |
Principles of Consolidation | h. Principles of Consolidation The accompanying consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary, Yummies, SG. All significant intercompany transactions and balances have been eliminated. |
Foreign Currency Translation | i. Foreign Currency Translation The Company follows Section 830-10-45 of the FASB Accounting Standards Codification (“Section 830-10-45”) for foreign currency translation to translate the financial statements of the foreign subsidiary from the functional currency, generally the local currency, into U.S. Dollars. Section 830-10-45 sets out the guidance relating to how a reporting entity determines the functional currency of a foreign entity (including of a foreign entity in a highly inflationary economy), re-measures the books of record (if necessary), and characterizes transaction gains and losses. the assets, liabilities, and operations of a foreign entity shall be measured using the functional currency of that entity. An entity’s functional currency is the currency of the primary economic environment in which the entity operates; normally, that is the currency of the environment, or local currency, in which an entity primarily generates and expends cash. The functional currency of each foreign subsidiary is determined based on management’s judgment and involves consideration of all relevant economic facts and circumstances affecting the subsidiary. Generally, the currency in which the subsidiary transacts a majority of its transactions, including billings, financing, payroll and other expenditures, would be considered the functional currency, but any dependency upon the parent and the nature of the subsidiary’s operations must also be considered. If a subsidiary’s functional currency is deemed to be the local currency, then any gain or loss associated with the translation of that subsidiary’s financial statements is included in accumulated other comprehensive income. However, if the functional currency is deemed to be the U.S. Dollar, then any gain or loss associated with the re-measurement of these financial statements from the local currency to the functional currency would be included in the consolidated statements of comprehensive income (loss). If the Company disposes of foreign subsidiaries, then any cumulative translation gains or losses would be recorded into the consolidated statements of comprehensive income (loss). If the Company determines that there has been a change in the functional currency of a subsidiary to the U.S. Dollar, any translation gains or losses arising after the date of change would be included within the statement of comprehensive income (loss). Based on an assessment of the factors discussed above, the management of the Company determined the relevant subsidiaries’ local currencies to be their respective functional currencies. |
Going Concern | j. Going Concern As shown in the accompanying financial statements, the Company incurred a net loss of $324 during the three months ended December 31, 2022 and accumulated losses of $349,717 since inception at June 10, 1998 |
Summary of Business and Signi_2
Summary of Business and Significant Accounting Policies (Details) - USD ($) | 3 Months Ended | |||
Dec. 31, 2023 | Dec. 31, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
Summary of Business and Significant Accounting Policies [Abstract] | ||||
Net loss | $ (324) | $ (10,687) | ||
Accumulated losses | (349,717) | $ (349,393) | ||
Current liabilities exceed its current assets | $ (10,611) | $ 9,348 | $ (13,772) | $ 18,735 |
Issuance of Common Stock (Detai
Issuance of Common Stock (Details) - USD ($) | 1 Months Ended | |||||
Aug. 31, 2020 | Oct. 31, 2019 | Feb. 28, 2019 | Dec. 31, 2023 | Sep. 30, 2023 | Dec. 17, 2018 | |
Issuance of Common Stock [Line Items] | ||||||
Common stock, shares authorized | 450,000,000 | 450,000,000 | ||||
Common stock, par value | $ 0.0001 | $ 0.0001 | ||||
Preferred stock, shares authorized | 50,000,000 | 50,000,000 | ||||
Preferred stock, par value | $ 0.0001 | $ 0.0001 | ||||
Minimum [Member] | ||||||
Issuance of Common Stock [Line Items] | ||||||
Common stock, shares authorized | 50,000,000 | |||||
Common stock, par value | $ 0.001 | |||||
Maximum [Member] | ||||||
Issuance of Common Stock [Line Items] | ||||||
Common stock, shares authorized | 450,000,000 | |||||
Common stock, par value | $ 0.0001 | |||||
Common Stock [Member] | ||||||
Issuance of Common Stock [Line Items] | ||||||
Common stock, shares issued | 121,500 | 3,527,393 | 446,472,607 | |||
Common stock price | $ 0.0001 | $ 0.0001 | $ 0.0001 | |||
Aggregate price | $ 12.15 | $ 44,647 | ||||
Common Stock [Member] | Common Stock [Member] | ||||||
Issuance of Common Stock [Line Items] | ||||||
Aggregate price | $ 352.74 | |||||
Issuance costs | $ 45,725 |
Income Taxes (Details)
Income Taxes (Details) - USD ($) | 3 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Income Taxes [Abstract] | ||
Loss carry forwards | $ 349,717 | $ 297,005 |
Net operating losses | $ 0 |